Drug and Alcohol Dependence

Article	Citations
Patient and provider experiences with opioid use disorder care delivered via telehealth: A systematic mixed-studies review	285
Examining Bi-directional links between distinct affect states and tobacco lapse during a cessation attempt	203
Naloxone distribution amidst shifting drug use patterns: Insights from a needs-based syringe services program	148
A randomized pilot trial of two forms of behavioral economics intervention to improve engagement in buprenorphine-naloxone treatment among patients with opioid use disorder	121
Bariatric surgery and alcohol and substance use: A case-control survey study	116
Validation of screening instruments for alcohol and substance use disorders among men and women in Eastern Cape, South Africa	100
Drug use and disability: A call to action	94
Utilizing telemedicine during COVID-19 pandemic for a low-threshold, street-based buprenorphine program	83
Effects of prenatal exposure to methadone or buprenorphine and maternal separation on anxiety-like behavior in rats	83
Opioid agonist therapy switching among individuals with prescription-type opioid use disorder: Secondary analysis of a pragmatic randomized trial	83
Pilot randomized trial of cognitive-behavioral treatment plus contingency management for quitting smoking and weight gain prevention among smokers with overweight or obesity	81
Birth order and alcohol-related mortality by ethnic origin and national context: Within-family comparisons for Finland and Sweden	74
Implementation Barriers and Facilitator to Screening, Brief Intervention, and Referral to Treatment (SBIRT) for Risky Drug Use in FGHC Primary Care Clinics in the COVID-19 era: The Quit-Mobile Study	71
Intentional Drug Overdose Deaths and Mood Disorders in Brazil - A 20-Year Overview	68
Project BETTER: A Randomized Feasibility Trial of a Technology-Delivered Intervention Among Pregnant People Receiving Medication for Opioid Use Disorder	61
Assessing the Use of Research Evidence in State-Level Substance Use Policy	60
Canadian Trends in Cannabis Use: Findings From the Canadian Cannabis Survey	60
Denial of Prescription Pain Medication Among People Who Use Drugs in Vancouver, Canada	58
Responding to Xylazine Adulteration: Qualitative Insights From People who Use Drugs and Syringe Services Program Staff	57
Medication Experiences in the Treatment for Opioid Use Disorder: Insights From Reddit	56
Longitudinal Associations between Frequency and Recency of Nonmedical Prescription Stimulant Use in Adolescence and Cocaine Use in Young Adulthood: Implications for Screening	55
Comparative Effectiveness of Intranasal Naloxone and Nalmefene in a Translational Model Assessing Reversal of Cardiac Arrest Induced by Synthetic Opioid Overdose	54
Secondary Analysis of Trials of Prolonged Exposure Therapy Among Adults With Co-Occurring Posttraumatic Stress Disorder and Opioid Use Disorder by Gender	52
Cigarette Smoking and Electronic Nicotine Product Use Among People With Stimulant Use Disorder – Estimates From the 2021 National Survey on Drug Use and Health.	49
Young Adult Perceptions on Cannabis Use and Driving While Impaired: The Next Generation	49

App-Based Contingency Management for Polysubstance Use: An Exploratory Analysis of App Engagement and Spending Patterns	48
Fentanyl Preference and Criminal Legal Involvement: Associations and Differential Outcomes by Incidence of Arrest	48
Relationships between Craving, Quality of Life, Health, and Cocaine Abstinence, With the Treatment Effectiveness Assessment in a Sample of People in Cocaine Dependence Treatment	47
Imprisonment Among People who Use Methamphetamine in Victoria, Australia: A Prospective Cohort Study	47
Primary Care Buprenorphine Provision in the US South and Midwest: Prescribing Changes Post-Data Waiver Elimination	46
Opioid Substitution Therapy Programs and the National Campaign to Eliminate Hepatitis C Virus in Taiwan: Current Status and Perspectives in a 2022 National Survey Among Medical Institutions	46
Leveraging Photovoice to Gain Perspectives From People With Lived Substance Use Experience on Drivers of the Opioid Epidemic, What can Help, and Using the Medium to Share Insights With Law-Makers	43
Providing Information and Advice in Brief Motivational Interventions: A Quantitative Process Analysis	43
Naltrexone for the Treatment of Amphetamine-type Stimulant Use Disorder: A Systematic Review and Meta-analysis of Randomized Placebo-controlled Trials	41
Real-Time Predictors of Cannabis Use Among Young Adults: An Ecological Momentary Assessment Study	40
Male Sex and Hazardous Alcohol Use following Military Sexual Assault Increase Suicide Risk Among Us Service Members and Veterans	40
Racial and Ethnic Disparities in Telehealth and Emergency Department Use Among Women With Substance Use Disorder during the COVID-19 Pandemic	40
Human Laboratory Demonstration of Clinically-Meaningful Differences in Sensitivity to Opioids- A Possible Behavioral Risk Phenotype	39
Prevalence and Correlates of Non-Prescribed Methadone Use Among Adults who Have Injected Drugs---Baltimore, Maryland, 2023	39
Prefrontal Cortex Projections to the Nucleus Accumbens Mediate Cocaine Seeking Induced by Conditioned and Discriminative Stimuli in Rats	39
The Effects of Acupuncture Stimulation at Shenmen (HT7) on Brain Stimulation Reward in Rats	37
Factors Associated With Self-Directed Discharge Among Hospitalized Individuals With a Substance Use Disorder	37
Associations between Recreational Cannabis Legislation and Driving under the Influence of Alcohol and Other Substances in the US	36
Cannabis Use and Its Association With Treatment Engagement and Other Substance use: Results From a 90-Day Daily Diary Study	36
Emerging Adults’ Reasons for Cannabis Use and Reductions in Use: Leveraging Qualitative Methods to Develop Novel Prevention Intervention Strategies	36
How Do Helping Behaviors Change over the First Six Months for Sober Living House Residents?	36
Enhancing Propranolol-Induced Inhibition of Cocaine-Related Reward Memory Reconsolidation: Impact on Cocaine Craving and Use	36
Chronic Oral Dosing of Cannabidiol (CBD) With and Without low Doses of Delta-9-Tetrahydrocannabinol (Δ-9-THC)	36
Why Do Patients Decline Buprenorphine in the Emergency Department? Direct Feedback From Ed Patients who Have Accepted and Declined Buprenorphine for Opioid Use Disorder	35
Cannabis and Alcohol Use Trajectories: A Qualitative Analysis of Contributing Factors and Interconnections	35
Reductions in Injection Equipment Sharing in Peer-Facilitated Hepatitis C Treatment	35
Daily Fluctuations in Motivation and Perceived Environmental Access of Nondrug Reward Among People in Opioid Use Disorder Recovery: Person- And Day-Level Associations with Experiencing Nondrug Reward	34
A Comparative Study of Behavioral Effects of Novel Designer Drugs in Male Rodents	34
Characterization of E-Commerce Cannabis-Derived Product Marketing Targeting Students, Veterans, and Active Military	34
Pharmacological Characterization of Substituted Nitazenes at Opioid Receptors	34
Communities at the Crossroads: Exploring Cultural Variations in Opioid Mortality Across the United States	34
Communities that Heal Intervention, Data 2000 Waivered Providers and Buprenorphine Prescribing: A Randomized Clinical Trial	34
Interactions Between Using E-Cigarettes and Setting an Abstinence Plan on Cigarette Smoking in LGBTQ+ Individuals	33
Ask the Experts: Community Engagement Studios to Inform Research on Cannabis Use in Cancer Symptom Management	33
Evaluating Non-Abstinence ENDPOINTS: The Viability of Drinking Risk Levels as Outcomes in Treatments for Comorbid Posttraumatic Stress Disorder and Substance Use Disorders	32
U. S. Non-medical Synthetic Drugs Situation, Policy, Controls and Regulations to Reduce Supply	32
Determination of Yohimbine's Reinforcing Actions in Male and Female Rats	32
“Oh man, You’re Just Going to die:” Police Officer’s Perceptions of Fentanyl Pre and Post an Occupational Risk Reduction Training	32
Sign- and Goal-Tracking in Humans: Associations With Drug and Alcohol Use	32
Closing the Gap: MIT’s Program on Entrepreneurship and Innovation for Substance Use Disorder (SUD)	32
Accessibility Barriers to Medications for Opioid Use Disorder Treatment: A Qualitative Study of Perspectives From Women With Opioid Use Disorder and Health and Criminal Justice Professionals	31
PTSD Diagnosis Increases the Mediating Effect of Distress Tolerance on Pain Interference and Opioid Misuse	31
Prenatal Exposure to Xylazine Using Umbilical Cord Tissue in an At-Risk Population	31
The Role of Chronic Pain in Smoking and Smoking Cessation: A Secondary Analysis of Program Data	31
Developing a Superior, Once-A-Day Oral Smoking Cessation Product Using Real-Time Biosensors	31
The Intersection of Cannabis Use and ADHD: Patterns, Correlates, and Clinical Implications	30
Healing Measurement Center Study Protocol to Enhance Opioid Use Disorder Recovery through Measurement Based Care	30
Behavioral Economic Interactions Between Cannabis and Delta-8	30
Pharmacology of Newer Synthetic Cannabinoids at the CB1 Receptor	30
Development of the Subject-Rated Comprehensive Drug Withdrawal Scale (CDWS) to Evaluate the Physical Dependence Potential of Investigational Drugs	30

Characterization of Reddit Posts on Nitazenes	30
Risk of COVID-19 Hospitalization and Death in Patients on Chronic Opioid Therapy and With Opioid Use Disorder	30
Intimate Partner Violence Victimization in Emerging Adulthood: Associations With Frequent Cannabis Use in Emerging and Early Adulthood	29
Nalfurafine is Aversive at Analgesic Doses - Non-Clinical Evidence to Indicate It is Not an Atypical Kappa Opioid Receptor Agonist	29
Patterns of Opioid Use Disorder Among Pregnant and Postpartum Women in the United States From 2015-2020	29
Exposure to Bupropion-Sr vs. Placebo is Associated With Reductions in Smoking Among Persons who are Receiving Methadone and Have no Stated Interest in Smoking Cessation	29
The Impact of Severe Mental Illness on Treatment Retention and All-Cause Mortality of Individuals in Opioid Agonist Treatment: A Retrospective Data Linkage Study	29
Anticipating the Impact of Bail Reform on Connecting People Who Use Drugs to Services Upon Reentry in Illinois: Stakeholder Perspectives From the Reducing Opioid Mortality in Illinois Study	29
Assessment of the Publication Trends of the Harm Reduction Studies over 40 Years	29
Anger Mediates the Relationship between Changes in Alcohol Consumption and violence: A Longitudinal Examination Among Iraq/Afghanistan-Era Veterans	29
A Pilot Trial of Symptom-Triggered Alcohol Withdrawal Management Delivered Over Telemedicine	28
The Impact of Mental Health on Retention in Oat	28
Detection of Benzodiazepines in British Columbia’s Unregulated Drug Supply Using Point-Of-Care Drug Checking technologies: A Validation Study	28
Piloting Virtual Shared Medical Appointments Among Individuals With Opioid Use Disorder	28
Efficacy of Contingency Management Approaches for Cannabis Use Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials	27
Misrepresentation of MDMA in the United States, 1999–2023	27
Trauma-Related Help-Seeking Among Women in Substance Use Treatment: Barriers to Care and Recommendations for Improving Service Delivery	27
Decoding Multisystem Intervention Barriers to Women’s Residential SUD Treatment: A Multisite Qualitative Study	26
Beyond Rest: Unraveling the Nexus of Sleep Deficiency, Environment, Control, and their Influence on Opioid Use Disorder Treatment Outcomes	26
Identifying Subtypes of Cannabis Use Disorder and Cannabis Consumption Predictors among Daily Cannabis Consumers	26
Novel Intervention to Improve Food Insecurity among Individuals with Opioid Use Disorder	26
Estimating the societal cost of heroin dependence in an Australian population engaged in treatment or harm reduction services	26
Parental Mental Health and Family Conflict on Behavioral Inhibition and Activation Among Youth in the ABCD Study®	26
Self-Reported Knowledge, Preference, and Perceived Effects of Xylazine among Adults in Substance Use Disorder Treatment	26
First-In-Human Study of the Safety, Tolerability and Pharmacokinetics of CSX-1004, an Investigational Anti-Fentanyl Monoclonal Antibody	26
Training and Technical Assistance for Peer-Delivered Contingency Management	26
Receiving Medications for Opioid Use Disorder in Maryland Correctional Facilities and at a Community-Based Low-Threshold Buprenorphine Program Post-Release: Patient and Staff Perspectives	26
Development and Validation of Prediction Models for Perioperative Opioid Requirements: Integrating Machine-Learning Approach with Conventional Regression Method	26
TRANSLATIONALLY EVALUATING CAUSES AND CONSEQUENCES OF XYLAZINE ADULTERATION IN THE OPIOID SUPPLY	25
Baseline Demographic and Clinical Profile Differences in Individuals Initiating Medication for Opioid Use Disorder Treatment: Exploring the Role of Alcohol and Tobacco Smoking Co-Addiction	25
PRESIDENT’S REMARKS AND AWARDS	25
UTILIZING INNOVATIVE APPROACHES TO ENHANCE THE FULL POTENTIAL OF SUBSTANCE USE DATA TO BENEFIT MINORITIZED POPULATIONS	25
DRUG CHECKING: WHAT RESEARCHERS NEED TO KNOW	25
Perceived Impact of COVID-19 on Substance Use Among People Who Use Opioids (PWUO) in the Southeastern United States	24
Comparing Racial and Ethnic Differences on Access to Wellness Services for People in Substance Use Treatment	24
Provider Perspectives on Child Protective Services Reporting for Perinatal Patients With Opioid Use Disorder	24
LET’S BE BLUNT: NEUROCOGNITIVE IMPACTS OF CANNABINOIDS ARE COMPLICATED	24
Functional Impairment in Daily Living during Long-Term Remission From Substance Use Disorders	24
Design and Illicit Manufacture of Synthetic Drugs	24
Budget Impact Tool for Integrating Buprenorphine and Outpatient Parenteral Antibiotic Therapy for People who Inject Drugs Hospitalized With Severe Infections	23
CUE REACTIVITY AS A PARADIGM TO ASSESS AND INTERVENE IN ADDICTION ACROSS SPECIES	23
COMPUTATIONAL ADDICTION PSYCHIATRY: THEORY- AND DATA-DRIVEN APPROACHES TO TACKLE COMPLEX PHENOTYPES IN SUBSTANCE USE DISORDER	23
Seeking Treatment while Unhoused: A Qualitative Study Investigating the Experiences of People Experiencing Homelessness Enrolled in Outpatient Methadone Treatment	23
Orexin Receptor Mechanisms Involved in Methamphetamine-Induced Sleep Disruption in Female Rhesus Monkeys	23
PRACTICAL ASPECTS OF WORKING WITH VULNERABLE POPULATIONS AND PRACTICING COMMUNITY ENGAGED RESEARCH	23
Evaluation of Antidepressant and Anxiolytic Effects of Medicinal Cannabis Use via Ecological Momentary Assessments	22
Neurochemical and Behavioral Effects of Cannabinoid CB1 Agonist in Male Mice	22
BRIDGING THE GAP: PRACTICAL AND ETHICAL CONSIDERATIONS ON THE UTILITY OF ARTIFICIAL INTELLIGENCE IN SUBSTANCE USE DISORDERS	22
Guanfacine Reduces Drug Craving, Stress and Increases the Number of Abstinence Days in Women With Polysubstance Use Disorder (PSUD): A Pilot 2-Site Clinical Study	22
The Continuing Care Mobile Application for Justice-Involved Individuals With Substance Use Disorders: Findings From an Initial Randomized Trial	22
Cortical Functional Activation during Risky Decision-Making Associated to Youth Substance Use Initiation	22
“Do They Really Want the Help?” Barriers and Facilitators to Substance Use Treatment for Young Adults Experiencing Homelessness	22
Individualized Targeting of Frontolimbic Networks in People with Methamphetamine Use Disorder: Multi Target Optimization Using Neuroimaging	22
Collecting Abuse-related Adverse Event Information in Clinical Trials of Psychedelics and Novel Psychoactive Drugs to Inform Scheduling and Labeling: Issues, Methods, and Recommendations	22
Characterizing Substance Use Disorder on Reddit Through Network Analysis and Transitions of Use Between Opioids, Cannabis, and Other Drugs	22
Understanding the Interplay: Substance Use, Health Literacy, Self-Efficacy and HIV Worry in Sexual Risk Behaviors	22
The Association between Poly-victimization and Opioid Misuse Among Justice-Involved Adolescents	22
Investigating the Effects of Cue-Reactivity in Young Adult Vapers Using Functional Mri	21
NAVIGATING A CAREER IN ADDICTION SCIENCE: A WORKSHOP PRESENTED BY THE EARLY CAREER MEMBER COMMITTEE	21
Analyzing the Association of School Exclusion Disciplines on Opioid Misuse Among Justice-Involved Adolescents	21
Adolescent Gender Diversity and Substance Use Exposure: A Mediating Role of Peer Victimization	21
ON THE CUTTING EDGE - ADVANCING THE METHODS TO EVALUATE ABUSE AND DEPENDENCE-POTENTIAL IN PRECLINICAL AND CLINICAL STUDIES	21
Nicotine-Induced Facilitation of Punishment Resistant Fentanyl Consumption: the Role of Striatal Mechanisms	21
Nicotine Use Sex-Specifically Dysregulates Microglial Structure Within the Nucleus Accumbens	21
The Landscape of HIV Services Delivery in U.S. Syringe Services Programs: A Qualitative Exploration of Current Models and Opportunities	21
Exploration of Substance Use Recurrence by Psychiatric Comorbidities within a Sample of Pregnant Patients in Treatment for Opioid Use Disorder	21
Risky Polysubstance Use Among People who Use Opioids in a Community-Based Study	21
Misuse Potential of Medicinal Ketamine in Real-World Clinical Contexts, Part 1: Patients With At-Home Prescribed Ketamine	21
Strategies to Improve Equitable and Evidence-Based Hospital Care for Pregnant People With a Substance Use Disorder: A Rapid Scoping Review	21
CPDD Public Policy Committee Forum: Data, Policies, and Experiences From Around the World on Overdose Prevention Centers (aka Drug Consumption Rooms, Supervised Consumption Sites)	20
“When She’s there, I No Longer Worry about Her Being arrested” – Family Perspectives on Compulsory Drug Rehabilitation in Vietnam and Implications for Community-Based Approaches	20
Placebo Effect and Its Impact on Human Abuse Potential Studies	20
A Quality Improvement Incentive-Based Program with Micro-Randomized Messages to Improve Smoking Cessation in Low-Resource Populations	20
Source Localized Auditory Erp Sensory and Preattentive Correlates of Psilocybin-Induced Ego-Dissolution Related Effects	20
Cellular Effects of Cannabinoids in Adolescent Cortex: A Translational Study in Mice and Humans	20
An Emulated Trial of Buprenorphine-Naloxone Versus Extended-Release Naltrexone Following Medically Managed Opioid Withdrawal	20
The Impact of Low Family Engagement on Opioid Misuse Among Justice Involved Adolescents	20
Opioid-associated Dysregulation of CD14+ Monocytes Among People Living with HIV	20
Effects of Gabapentinoids on the Discriminative Stimulus Effects of Fentanyl and Cocaine in Male Rats	20
Increasing Rates of Stimulant Use Among Patients With Opioid Use Disorder Receiving Substance Use Treatment: Findings From a Prospective Cohort Study	20

Sex Differences in Contextual Cocaine Seeking Behavior are Driven by Noradrenergic Signaling to the Dorsal Hippocampus	20
Cannabis Use in Young Adults: The Role of Neighborhood Cohesion	20
Comparison of Contingency Management Protocols for Reducing Illicit Drug Use Among a Community-Based Sample of Women Engaging in Polysubstance Use	20
Clinical Translation of the HR/LR Model of SUD Propensity	20
Repetitive Transcranial Magnetic Stimulation for the Treatment of Suicidality in Opioid Use Disorder: A Pilot Feasibility Randomized Controlled Trial	20
Characterizing Barriers to Substance Use treatment: A Latent Class Analysis Using the NSDUH 2020-2021 Surveys	20
Predicting Alcohol Use Patterns From Diverse Longitudinal Datasets Using Novel Machine Learning Techniques	19
QUIERO SER YO: A LATINO TRANSGENDER MAN'S JOURNEY	19
SOCIAL MEDIA ADVERTISEMENTS TO PROMOTE SOCIAL-NETWORK STUDY PARTICIPATION IN LATINO MEN WHO HAVE SEX WITH MEN (LMSM): IMPLICATIONS AND LESSONS LEARNED	19
DEVELOPMENT OF AN EMA PROTOCOL FOR PRIMARILY SPANISH-SPEAKING PARTICIPANTS: LESSONS LEARNED	19
AUTOETHNOGRAPHY: TESTIMONIO OF A LATINA NAVIGATING GRADUATE SCHOOL AND ADDICTION RESEARCH	19
MIGRATION TRAUMA AND IMMIGRATION STRESS AS PREDICTORS OF DEPRESSIVE SYMPTOMS AMONG RECENT LATINO IMMIGRANTS IN SOUTH FLORIDA: A LATENT CLASS ANALYSIS	19
Examining Inadequate Response to Substance Use Disorder Treatment: A Scoping Review	19
CESSATION FROM CHRONIC NICOTIEN VAPOR EXPOSURE INCEASES INTRACRANIAL SELF-STIMULATION THRESHOLDS IN ADULT MALE AND FEMALE RATS	19
EXPLORING ASSOCIATIONS BETWEEN TRADITIONAL GENDER NORMS AND PRE-IMMIGRATION SEXUAL RISK BEHAVIORS AMONG MALE & FEMALE RECENT LATINO/A IMMIGRANTS	19
EXAMINING THE EFFECTS OF DISPOSITIONAL AUTONOMY ON INTERGENERATIONAL CONFLICT AND ALCOHOL USE WITHIN HISPANIC MALE AND FEMALE COLLEGE STUDENTS	19
Craving and Its Dynamics as Predictors of Stimulants use: An Ecological Momentary Assessment Study	19
ACUTE STIMULANT TOXICITY: THIS IS NOT OPIOID OVERDOSE	19
Characterizing Cardiovascular Health Among Individuals With Opioid Use Disorder	19
FRAILTY IS ASSOCIATED WITH CHANGES IN GUT BACTERIAL ABUNDANCE IN PEOPLE LIVING WITH HIV	19
QUALITATIVE SATISFACTION ANALYSIS OF WOMEN WITH PTSD SYMPTOMS AND SUD CRAVINGS IN A MOMENT-BY-MOMENT MINDFULNESS INTERVENTION	19
Impact of COVID-19 on stimulant use disorder treatment: A national cohort study in the Veterans Health Administration	18
Fentanyl preference among people who use opioids in New York City	18
Trends in pharmacy-based dispensing of buprenorphine, extended-release naltrexone, and naloxone during the COVID-19 pandemic by age and sex – United States, March 2019 – December 2020	18
Assessment of abuse liability and switching potential of menthol-flavored pod-based electronic nicotine delivery systems among US adults who smoke cigarettes	18
Vaping and psychotic experiences among college students in the United States	18
EFFECTS OF SOCIAL DEFEAT STRESS EXPOSURE ON SPATIAL MEMORY PERFORMANCE IN SOCIALLY MONOGAMOUS MALE PRAIRIE VOLES	18
Prevalence and associations of classic psychedelic-related seizures in a population-based sample	18
Electronic nicotine delivery systems use predicts transitions in cigarette smoking among young adults	18
PRENATAL ALCOHOL AND CANNABINOID EXPOSURE DECREASES MOTOR COORDINATION AND INCREASES ETHANOL SELF-ADMINISTRATION IN ADULT MOUSE OFFSPRING.	18
Buprenorphine abuse and health risks in Iran: A systematic review	18
Attentional ERPs in consumers of smoked and insufflated cocaine associated with neuropsychological performance	18
Effect of HIV, antiretrovirals, and genetics on methadone pharmacokinetics: Results from the methadone antiretroviral pharmacokinetics study	18
Nine-year substance use treatment outcomes with buprenorphine for opioid use disorder in a federally qualified health center	18
Geo-spatial risk factor analysis for drug overdose death in South Florida from 2014 to 2019, and the independent contribution of social determinants of health	18
Bridge clinic implementation of “72-hour rule” methadone for opioid withdrawal management: Impact on opioid treatment program linkage and retention in care	18
Comparison of the Bluetooth iCOquit, piCO, and Vitalograph for the assessment of breath carbon monoxide among adults initiating smoking cessation and standardized canisters	18
Reply to Foxon F. & Shiffman S. Regarding Comments on “Adjei et al. 2024 Symptoms of nicotine dependence by E-cigarette and cigarette use behavior and brand: A population-based, nationally represe	18
Modeling the impact of interventions during an outbreak of HIV infection among people who inject drugs in 2012–2013 in Athens, Greece.	18
Oxycodone-related deaths in Sweden 2006–2018	18
SEX AND GENOTYPE DEPENDENT DRUG-INDUCED DOPAMINE RELEASE IN ADOLESCENT CHRNA6 3’-UTR RATS	18
Types of criminal legal system exposure and polysubstance use: Prevalence and correlates among U.S. adults in the National Survey on Drug Use and Health, 2015–2019	18
Reporting on Addiction: An Innovative, Collaborative Approach to Reduce Stigma by Improving Media Coverage and Public Messaging about Addiction Treatment and Recovery	17
Examination of gamma-aminobutyric acid and glutamate-glutamine levels in association with impulsive behavior in adolescent marijuana users	17
Editorial Board	17
Impact of California’s tobacco and cannabis policies on the retail availability of little cigars/cigarillos and blunt wraps	17
Women-centered drug treatment models for pregnant women with opioid use disorder: A scoping review	17
Pregnant women’s alcohol consumption and knowledge about its risks: An Israeli survey	17
To end the opioid crisis, we must address painful social disparities	17
Worsening trends in the frequency of methamphetamine and other stimulant use between treatment admission and discharge	17
Injecting practices during and after hepatitis C treatment and associations with not achieving cure among persons who inject drugs	17
Left frontal pole repetitive transcranial magnetic stimulation reduces cigarette cue-reactivity in correlation with verbal memory performance	17
Editorial Board	16
Are short AUDIT screeners effective in identifying unhealthy drinking of varying severity? A prison population study	16
Genetic Insights into the causal relationship between cannabis use and diabetic phenotypes: A genetic correlation and Mendelian randomization study	16
Understanding the impact of the COVID-19 pandemic on substance use and HIV	16
A novel long-acting formulation of oral buprenorphine/naloxone produces prolonged decreases in fentanyl self-administration by rhesus monkeys	16
Alcohol-attributable deaths and years of potential life lost due to alcohol among veterans: Overall and between persons with minoritized and non-minoritized sexual orientations	16
Reply to: Decrease in prevalence but increase in frequency of non-marijuana drug use following the onset of the COVID-19 pandemic in a large cohort of young men who have sex with men and young transge	16
Patterns of opioid and benzodiazepine use with gabapentin among disabled Medicare beneficiaries – A retrospective cohort study	16
Does food use disorder exist? Item response theory analyses of a food use disorder adapted from the DSM-5 substance use disorder criteria in a treatment seeking clinical sample	16
Cost of Hepatitis C care facilitation for HIV/Hepatitis C Co-infected people who use drugs	16
Measurement of public health impacts of cannabis legalization in Canada to reflect policy maker priorities: A rapid scoping review of instruments and content domains	16
Facilitating treatment initiation and reproductive care postpartum to prevent substance-exposed pregnancies: A randomized bayesian pilot trial	16
Drug and alcohol dependence acute effects of pod-style e-cigarettes in vaping-naïve smokers	16
New-onset addictions in patients with alcohol dependence: A cross-sectional study	16
Editorial Board	16
Comparative analysis between CDT in serum and Ethyl glucuronide in hair to define the best reliable tool for the diagnosis of alcohol abuse	16
Examining how the geographic availability of alcohol within residential neighborhoods, activity spaces, and destination nodes is related to alcohol use by parents of young children	16
Hospitalisation following therapeutic community drug and alcohol treatment for young people with and without a history of criminal conviction	16
Effect of menthol/mint-flavored pods on young JUUL E-cigarette users’ subjective experience, puffing behavior, and nicotine exposure: A pilot study	16
Letter to the Editor regarding: Is implementation of ASAM-based addiction treatment assessments associated with improved 30-day retention and substance use? (By Mark et al., 2021)	16
Acceptability and participation predictors for a pragmatic randomized controlled trial to test a smoking cessation intervention after discharge from mental health wards	15
Editorial Board	15
Development and validation of the Schedule for the Assessment of Insight in Alcohol Dependence (SAI-AD): Dimensions and correlates of insight in alcohol use disorder	15
The frequency of severe Fetal Alcohol Spectrum Disorders in the neonatal period using data from the French hospital discharge database between 2006 and 2013	15
Buprenorphine/naloxone and methadone effectiveness for reducing craving in individuals with prescription opioid use disorder: Exploratory results from an open-label, pragmatic randomized controlled tr	15
Community-, network-, and individual-level predictors of uptake of medication for opioid use disorder among young people who inject drugs and their networks: A multilevel analysis	15
Alcohol consumption patterns and unhealthy aging among older lifetime drinkers from Spain	15
Validity of the DSM-5 tobacco use disorder diagnostics in adults with problematic substance use	15
Emotional distress and pain catastrophizing predict cue-elicited opioid craving among chronic pain patients on long-term opioid therapy	15
Editorial Board	15
Screening in Trauma for Opioid Misuse Prevention (STOMP): Results from a prospective cohort of victims of traumatic injury	15
Influence of nicotine form and nicotine flux on puffing behavior and mouth-level exposure to nicotine from electronic nicotine delivery systems	15
Does substance use disorder treatment completion reduce the risk of treatment readmission in Chile?	15
Editorial Board	15
Editorial Board	15
Non-prescribed pharmaceutical stimulants use among adolescents: A way to self-care or peer success?	15
The role of virtual socializing and unstructured socializing in adolescent vaping	15
Receipt of opioid use disorder treatments prior to fatal overdoses and comparison to no treatment in Connecticut, 2016–17	15
Ethanol drinking at adulthood is sensitive to S1-R antagonism and is promoted by binge ethanol self-administration at adolescence	15
Efficacy of ketamine intervention to decrease alcohol use, cravings, and withdrawal symptoms in adults with problematic alcohol use or alcohol use disorder: A systematic review and comprehensive analy	14
Trends in comorbid opioid and stimulant use disorders among Veterans receiving care from the Veterans Health Administration, 2005–2019	14
Epigenetic effects of cannabis: A systematic scoping review of behavioral and emotional symptoms associated with cannabis use and exocannabinoid exposure	14
Alcohol consumption and dependence risk among male and female Veterans: Trajectories and predictors	14